110 related articles for article (PubMed ID: 9063499)
1. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas.
Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
APMIS; 1997 Jan; 105(1):35-40. PubMed ID: 9063499
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas.
Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
Br J Dermatol; 1997 Jan; 136(1):30-4. PubMed ID: 9039291
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.
Haerslev T; Rossen K; Hou-Jensen K; Jacobsen GK
Acta Derm Venereol; 1995 May; 75(3):187-9. PubMed ID: 7653177
[TBL] [Abstract][Full Text] [Related]
4. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
Rossen K; Hou-Jensen K; Werdelin O
Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
[TBL] [Abstract][Full Text] [Related]
6. Epidermal basaloid cell hyperplasia overlying dermatofibromas.
Lindboe CF; Løvdal L
Am J Dermatopathol; 2011 Feb; 33(1):52-5. PubMed ID: 21178581
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: immunohistochemical characterization.
Han KH; Huh CH; Cho KH
Am J Dermatopathol; 2001 Apr; 23(2):90-8. PubMed ID: 11285402
[TBL] [Abstract][Full Text] [Related]
8. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
9. Epidermal basaloid proliferation in cutaneous myxomas.
Mehregan DR; Thomas L; Thomas JE
J Cutan Pathol; 2003 Sep; 30(8):499-503. PubMed ID: 12950501
[TBL] [Abstract][Full Text] [Related]
10. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
Stashower ME; Smith K; Corbett D; Skelton HG
J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
[TBL] [Abstract][Full Text] [Related]
11. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
[TBL] [Abstract][Full Text] [Related]
12. Basal cell carcinomas and basal cell carcinoma-like changes overlying dermatofibromas.
Goette DK; Helwig EB
Arch Dermatol; 1975 May; 111(5):589-92. PubMed ID: 165782
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
14. BAX protein is not expressed by basal cell carcinomas.
Rossen K; Karabulut Thorup A; Hou-Jensen K; Krag Jacobsen G
Br J Dermatol; 1998 Sep; 139(3):472-4. PubMed ID: 9767293
[TBL] [Abstract][Full Text] [Related]
15. [Basal cell carcinoma overlying a dermatofibroma].
Córdoba S; Hernández A; Romero A; Arias D; Castaño E; García-Donoso C; Borbujo JM
Actas Dermosifiliogr; 2005 Nov; 96(9):612-5. PubMed ID: 16476308
[TBL] [Abstract][Full Text] [Related]
16. Bax expression and growth behavior of basal cell carcinomas.
Tilli CM; Stavast-Koey AJ; Ramaekers FC; Neumann HA
J Cutan Pathol; 2002 Feb; 29(2):79-87. PubMed ID: 12150137
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibroma: upregulation of syndecan-1 expression in mesenchymal tissue.
Sellheyer K; Smoller BR
Am J Dermatopathol; 2003 Oct; 25(5):392-8. PubMed ID: 14501288
[TBL] [Abstract][Full Text] [Related]
18. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
Ramdial PK; Madaree A; Reddy R; Chetty R
J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
20. Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67.
Yang XJ; McEntee M; Epstein JI
Hum Pathol; 1998 Dec; 29(12):1447-50. PubMed ID: 9865831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
